首页> 外国专利> PYRAZOLE CARBOXAMIDE DERIVATIVES AS TAAR REGULATOR FOR USE IN TREATMENT OF SEVERAL DISORDERS SUCH AS DEPRESSION, DIABETES AND PARKINSON'S DISEASE

PYRAZOLE CARBOXAMIDE DERIVATIVES AS TAAR REGULATOR FOR USE IN TREATMENT OF SEVERAL DISORDERS SUCH AS DEPRESSION, DIABETES AND PARKINSON'S DISEASE

机译:吡唑羧酰胺衍生物作为TAAR调节剂,可用于治疗多种抑郁症,例如抑郁症,糖尿病和帕金森氏病

摘要

PROBLEM TO BE SOLVED: To provide pyrazole carboxamide derivatives as a trace amine associated receptor (TAAR) regulator that may be used for treatment of depression, anxiety disorder, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorder, psychotic disorder such as schizophrenia, and neurological disease such as Parkinson's disease.SOLUTION: The problem is solved by a compound represented by formula (I) or a pharmaceutically suitable acid addition salt thereof. [Z is a bond, CHor O; Ris halogen, cyano, substituted/unsubstituted alkyl, cycloalkyl, substituted/unsubstituted phenyl, or the like; Ris H or alkyl; and Ris H, amino, or alkyl.]SELECTED DRAWING: None
机译:解决的问题:提供吡唑甲酰胺衍生物作为痕量胺相关受体(TAAR)调节剂,可用于治疗抑郁症,焦虑症,双相情感障碍,注意力缺陷多动障碍(ADHD),压力相关性障碍,精神病解决方案:该问题通过式(I)代表的化合物或其药学上合适的酸加成盐解决。 [Z是键,CHor O;卤素,氰基,取代/未取代的烷基,环烷基,取代/未取代的苯基等;氢或烷基;和Ris H,氨基或烷基。]

著录项

  • 公开/公告号JP2017122103A

    专利类型

  • 公开/公告日2017-07-13

    原文格式PDF

  • 申请/专利权人 F. HOFFMANN-LA ROCHE AG;

    申请/专利号JP20170031116

  • 申请日2017-02-22

  • 分类号C07D401/12;C07D413/12;A61K31/5377;C07D413/14;C07D403/12;A61K31/4155;A61K31/454;C07D417/14;C07D405/14;A61P25/24;A61P25/22;A61P25;A61P25/18;A61P25/16;A61P25/28;A61P25/08;A61P25/06;A61P9/12;A61P25/36;A61P3;A61P3/10;A61P3/04;A61P3/06;A61P9;

  • 国家 JP

  • 入库时间 2022-08-21 14:01:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号